MBI
BMY icon

Montrusco Bolton Investments’s Bristol-Myers Squibb BMY Stock Holding History

Montrusco Bolton Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,580
Closed -$144K – 76
2017
Q2 		$144K Buy
+2,580
New +$140K 0.01% 78

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Montrusco Bolton Investments's BMY Position: Q3 2017 in Review

Montrusco Bolton Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 2,580 shares — an estimated $144K sold.

Montrusco Bolton Investments first reported a position in BMY in Q2 2017 and held it in 1 quarter. The position peaked at $144K in Q2 2017. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Montrusco Bolton Investments reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • Montrusco Bolton Investments sold 2,580 Bristol-Myers Squibb shares in Q3 2017, an estimated $144K.
  • Montrusco Bolton Investments first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 1 quarter.
  • Montrusco Bolton Investments's Bristol-Myers Squibb position peaked at $144K in Q2 2017.
  • 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Montrusco Bolton Investments's 13F filing for Q3 2017, filed 18 Oct 2017.